BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19637981)

  • 21. Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles.
    Harvie P; Wong FM; Bally MB
    J Pharm Sci; 2000 May; 89(5):652-63. PubMed ID: 10756331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new triantennary galactose-targeted PEGylated gene carrier, characterization of its complex with DNA, and transfection of hepatoma cells.
    Frisch B; Carrière M; Largeau C; Mathey F; Masson C; Schuber F; Scherman D; Escriou V
    Bioconjug Chem; 2004; 15(4):754-64. PubMed ID: 15264862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery.
    Heyes J; Hall K; Tailor V; Lenz R; MacLachlan I
    J Control Release; 2006 May; 112(2):280-90. PubMed ID: 16603272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake.
    Takara K; Hatakeyama H; Ohga N; Hida K; Harashima H
    Int J Pharm; 2010 Aug; 396(1-2):143-8. PubMed ID: 20457236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors.
    Takae S; Miyata K; Oba M; Ishii T; Nishiyama N; Itaka K; Yamasaki Y; Koyama H; Kataoka K
    J Am Chem Soc; 2008 May; 130(18):6001-9. PubMed ID: 18396871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting DNA mismatches with rhodium intercalators functionalized with a cell-penetrating peptide.
    Brunner J; Barton JK
    Biochemistry; 2006 Oct; 45(40):12295-302. PubMed ID: 17014082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular uptake and intracellular pathways of PLL-g-PEG-DNA nanoparticles.
    Lühmann T; Rimann M; Bittermann AG; Hall H
    Bioconjug Chem; 2008 Sep; 19(9):1907-16. PubMed ID: 18717536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes.
    Song LY; Ahkong QF; Rong Q; Wang Z; Ansell S; Hope MJ; Mui B
    Biochim Biophys Acta; 2002 Jan; 1558(1):1-13. PubMed ID: 11750259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acylation of octaarginine: Implication to the use of intracellular delivery vectors.
    Katayama S; Hirose H; Takayama K; Nakase I; Futaki S
    J Control Release; 2011 Jan; 149(1):29-35. PubMed ID: 20144669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different oligoarginine modifications alter endocytic pathways and subcellular trafficking of polymeric nanoparticles.
    Zhou J; Chau Y
    Biomater Sci; 2016 Oct; 4(10):1462-72. PubMed ID: 27532744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylation.
    Hayes ME; Drummond DC; Hong K; Zheng WW; Khorosheva VA; Cohen JA; C O N; Park JW; Marks JD; Benz CC; Kirpotin DB
    Mol Pharm; 2006; 3(6):726-36. PubMed ID: 17140260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery.
    Kamei N; Morishita M; Ehara J; Takayama K
    J Control Release; 2008 Oct; 131(2):94-9. PubMed ID: 18692532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stabilized plasmid-lipid particles: construction and characterization.
    Wheeler JJ; Palmer L; Ossanlou M; MacLachlan I; Graham RW; Zhang YP; Hope MJ; Scherrer P; Cullis PR
    Gene Ther; 1999 Feb; 6(2):271-81. PubMed ID: 10435112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of alpha-and beta-oligoarginine-acids and amides with anionic lipid vesicles: a mechanistic and thermodynamic study.
    Hitz T; Iten R; Gardiner J; Namoto K; Walde P; Seebach D
    Biochemistry; 2006 May; 45(18):5817-29. PubMed ID: 16669625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors.
    del Pozo-Rodríguez A; Pujals S; Delgado D; Solinís MA; Gascón AR; Giralt E; Pedraz JL
    J Control Release; 2009 Jan; 133(1):52-9. PubMed ID: 18854203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoplex morphologies and their influences on transfection efficiency in gene delivery.
    Ma B; Zhang S; Jiang H; Zhao B; Lv H
    J Control Release; 2007 Nov; 123(3):184-94. PubMed ID: 17913276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oligoarginine vectors for intracellular delivery: design and cellular-uptake mechanisms.
    Futaki S
    Biopolymers; 2006; 84(3):241-9. PubMed ID: 16333858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folate-equipped pegylated archaeal lipid derivatives: synthesis and transfection properties.
    Lainé C; Mornet E; Lemiègre L; Montier T; Cammas-Marion S; Neveu C; Carmoy N; Lehn P; Benvegnu T
    Chemistry; 2008; 14(27):8330-40. PubMed ID: 18668503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of poly(amidoamine) dendron-bearing lipids with poly(ethylene glycol) grafts and their use for stabilization of nonviral gene vectors.
    Takahashi T; Hirose J; Kojima C; Harada A; Kono K
    Bioconjug Chem; 2007; 18(4):1163-9. PubMed ID: 17569497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acid cleavable PEG-lipids for applications in a ternary gene delivery vector.
    Wong JB; Grosse S; Tabor AB; Hart SL; Hailes HC
    Mol Biosyst; 2008 Jun; 4(6):532-41. PubMed ID: 18493650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.